home / stock / eols / eols news

EOLS News and Press, Evolus Inc. From 08/25/25

Stock Information
Company Name: Evolus Inc.
Stock Symbol: EOLS
Market: NASDAQ
Website: evolus.com
Menu
EOLS EOLS Quote EOLS Short EOLS News EOLS Articles EOLS Message Board
Get EOLS Alerts

News, Short Squeeze, Breakout and More Instantly...
EOLS - Evolus Announces Positive Data From Pivotal Trial for Evolysse(TM) Sculpt Injectable Hyaluronic Acid Gel Product at 2025 Cosmetic Bootcamp

Evolysse ™ Sculpt met the primary endpoint of non-inferiority and demonstrated statistical superiority to Restylane ® -Lyft The safety profile was similar between Evolysse ™ Sculpt and Restylane ® -Lyft and no treatment-related serious adverse event...
EOLS - Catalyst Watch: Eyes on Jackson Hole, Walmart report, Google event, and Foot Locker-Dick's vote

2025-08-15 15:00:59 ET More on the markets Forget The September Rate Cut AAII Sentiment Survey: Optimism Slides Slowing Growth And Rising Federal Debt Complicate U.S. Economic Outlook Trump-Putin summit: What to expect AI-linked investment lifted GDP ...

EOLS - AMC, Cisco Set To Report Earnings As Investors Watch Out For Core CPI

2025-08-09 11:00:00 ET Get ahead of the market by subscribing to Seeking Alpha's Wall Street Week Ahead, a preview of key events scheduled for the coming week. The newsletter keeps you informed of the biggest stories set to make headlines, including upcoming IPOs, investor days, earnings re...

EOLS - Catalyst Watch: Cisco earnings, Sailpoint lockup expiration, CPI read, and another crypto exchange IPO

2025-08-08 15:00:38 ET More on the markets July CPI Preview: More Evidence Of Stagflation Window Of Weakness? Capex Nation: Investment Themes For A Decade 10 stocks return 80% of S&P 500’s gains since ‘Liberation Day’ Nearly 5...
EOLS - Evolus plunges after Q2 miss, guidance cut; Needham downgrades

2025-08-06 15:31:08 ET More on Evolus Evolus, Inc. (EOLS) Q2 2025 Earnings Call Transcript Evolus, Inc. 2025 Q2 - Results - Earnings Call Presentation Evolus - A Slightly Risky Buy Ahead Of Q2 Earnings Evolus outlines $700M 2028 revenue target and cost realig...

EOLS - US Companies Moving the Markets, Morning edition
Wed, Aug 06, 2025 as of 10.00 am ET

A look at the top 10 most actives in the United States Safe & Green Holdings Corp. (SGBX) rose 141.6% to $0.4671 on volume of 363,657,432 shares BiomX Inc. (PHGE) rose 19.6% to $0.5201 on volume of 78,449,319 shares LivePerson Inc. (LPSN) rose 39.7% to $1.2404 on volume of 64,019,403 sh...

EOLS - Evolus outlines $700M 2028 revenue target and cost realignment amid market softness

2025-08-05 19:16:27 ET More on Evolus Evolus, Inc. (EOLS) Q2 2025 Earnings Call Transcript Evolus, Inc. 2025 Q2 - Results - Earnings Call Presentation Evolus - A Slightly Risky Buy Ahead Of Q2 Earnings Evolus GAAP EPS of -$0.27 misses by $0.07, revenue of $69...
EOLS - Evolus, Inc. (EOLS) Q2 2025 Earnings Call Transcript

2025-08-05 19:15:46 ET Evolus, Inc. (EOLS) Q2 2025 Earnings Conference Call August 05, 2025, 04:30 PM ET Company Participants David Moatazedi - President, CEO & Director Nareg Sagherian - Head of Global Investor Relations & Corporate Communications Rui Av...

EOLS - Evolus GAAP EPS of -$0.27 misses by $0.07, revenue of $69.4M misses by $12.64M

2025-08-05 16:09:02 ET More on Evolus Evolus - A Slightly Risky Buy Ahead Of Q2 Earnings Evolus, Inc. (EOLS) Q1 2025 Earnings Call Transcript Evolus projects $345M-$355M revenue for 2025 with new product launches Seeking Alpha’s Quant Rating on Evolus ...

EOLS - Evolus Reports Second Quarter 2025 Financial Results and Provides Business Updates

Global Net Revenue of $69.4 Million for Q2 2025, Up 4% from Q2 2024 in a Market Where Overall U.S. Aesthetic Procedures Decreased; Growth Driven by the Successful Launch of Evolysse ™ and Continued Strength in International Markets Evolysse ™ Delivered $9.7 Million i...
Previous 10 Next 10